{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:36:23Z","timestamp":1791401783483,"version":"4.3.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2308400"],"award-info":[{"award-number":["2023YFC2308400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072314"],"award-info":[{"award-number":["82072314"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-95950-7","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T10:50:06Z","timestamp":1744714206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genomic epidemiology and characterization of difficult-to-treat resistant Pseudomonas aeruginosa isolates co-harboring blaOXA-50 and crpP causing bronchiectasis"],"prefix":"10.1038","volume":"15","author":[{"given":"Lulu","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"shahzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"issue":"10","key":"95950_CR1","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","volume":"22","author":"WR Miller","year":"2024","unstructured":"Miller, W. R. & Arias, C. A. ESKAPE pathogens: Antimicrobial resistance, epidemiology, clinical impact and therapeutics. Nat Rev Microbiol 22(10), 598\u2013616 (2024).","journal-title":"Nat Rev Microbiol"},{"key":"95950_CR2","doi-asserted-by":"publisher","first-page":"110063","DOI":"10.1016\/j.vetmic.2024.110063","volume":"292","author":"AM Rizk","year":"2024","unstructured":"Rizk, A. M. et al. Phenotypic and genotypic characterization of resistance and virulence in Pseudomonas aeruginosa isolated from poultry farms in Egypt using whole genome sequencing. Vet Microbiol 292, 110063 (2024).","journal-title":"Vet Microbiol"},{"issue":"3","key":"95950_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cmi.2019.07.010","volume":"26","author":"YH Chai","year":"2020","unstructured":"Chai, Y. H. & Xu, J. F. How does Pseudomonas aeruginosa affect the progression of bronchiectasis?. Clin Microbiol Infect 26(3), 313\u2013318 (2020).","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"95950_CR4","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1016\/S2666-5247(22)00329-9","volume":"4","author":"J Reyes","year":"2023","unstructured":"Reyes, J. et al. Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): A prospective cohort study. Lancet Microbe 4(3), e159\u2013e170 (2023).","journal-title":"Lancet Microbe"},{"issue":"Suppl 1","key":"95950_CR5","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1093\/ofid\/ofy343","volume":"6","author":"D Shortridge","year":"2019","unstructured":"Shortridge, D. et al. Geographic and temporal patterns of antimicrobial resistance in Pseudomonas aeruginosa over 20 years from the SENTRY antimicrobial surveillance program, 1997\u20132016. Open Forum Infect Dis 6(Suppl 1), S63\u2013S68 (2019).","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"95950_CR6","doi-asserted-by":"publisher","first-page":"e0271221","DOI":"10.1128\/spectrum.02712-21","volume":"10","author":"D Shortridge","year":"2022","unstructured":"Shortridge, D., Streit, J. M., Mendes, R. & Castanheira, M. In vitro activity of Cefiderocol against U.S. and European gram-negative clinical isolates collected in 2020 as part of the SENTRY antimicrobial surveillance program. Microbiol Spectr 10(2), e0271221 (2022).","journal-title":"Microbiol Spectr"},{"issue":"7","key":"95950_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.00355-19","volume":"63","author":"DJ Diekema","year":"2019","unstructured":"Diekema, D. J. et al. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 63(7), 10\u20131128 (2019).","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"95950_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40121-024-01077-z","volume":"14","author":"I Machuca","year":"2025","unstructured":"Machuca, I. et al. Real-world experience of imipenem-relebactam treatment as salvage therapy in difficult-to-treat Pseudomonas aeruginosa infections (IMRECOR study). Infect Dis Ther 14(1), 283\u2013292 (2025).","journal-title":"Infect Dis Ther"},{"issue":"4","key":"95950_CR9","doi-asserted-by":"publisher","first-page":"dlab179","DOI":"10.1093\/jacamr\/dlab179","volume":"3","author":"F Lebreton","year":"2021","unstructured":"Lebreton, F. et al. A panel of diverse Pseudomonas aeruginosa clinical isolates for research and development. JAC Antimicrob Resist 3(4), dlab179 (2021).","journal-title":"JAC Antimicrob Resist"},{"issue":"12","key":"95950_CR10","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/cid\/ciy378","volume":"67","author":"SS Kadri","year":"2018","unstructured":"Kadri, S. S. et al. Difficult-to-treat resistance in gram-negative bacteremia at 173 US HOSPITALS: Retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents. Clin Infect Dis 67(12), 1803\u20131814 (2018).","journal-title":"Clin Infect Dis"},{"issue":"4","key":"95950_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/CMR.00031-19","volume":"32","author":"JP Horcajada","year":"2019","unstructured":"Horcajada, J. P. et al. Epidemiology and Treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin Microbiol Rev 32(4), 10\u20131128 (2019).","journal-title":"Clin Microbiol Rev"},{"key":"95950_CR12","doi-asserted-by":"publisher","first-page":"100640","DOI":"10.1016\/j.drup.2019.07.002","volume":"44","author":"J Botelho","year":"2019","unstructured":"Botelho, J., Grosso, F. & Peixe, L. Antibiotic resistance in Pseudomonas aeruginosa\u2014Mechanisms, epidemiology and evolution. Drug Resist Updat 44, 100640 (2019).","journal-title":"Drug Resist Updat"},{"issue":"1","key":"95950_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s13054-020-03091-2","volume":"24","author":"R Zaragoza","year":"2020","unstructured":"Zaragoza, R. et al. Update of the treatment of nosocomial pneumonia in the ICU. Crit Care 24(1), 383 (2020).","journal-title":"Crit Care"},{"issue":"9","key":"95950_CR14","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","volume":"180","author":"PA Flume","year":"2009","unstructured":"Flume, P. A. et al. Clinical practice guidelines for pulmonary therapies C: Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 180(9), 802\u2013808 (2009).","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"95950_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0041-1740109","volume":"43","author":"JP Lynch 3rd","year":"2022","unstructured":"Lynch, J. P. 3rd. & Zhanel, G. G. Pseudomonas aeruginosa pneumonia: Evolution of antimicrobial resistance and implications for therapy. Semin Respir Crit Care Med 43(2), 191\u2013218 (2022).","journal-title":"Semin Respir Crit Care Med"},{"key":"95950_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fmed.2019.00074","volume":"6","author":"M Bassetti","year":"2019","unstructured":"Bassetti, M., Peghin, M., Vena, A. & Giacobbe, D. R. Treatment of infections due to MDR gram-negative bacteria. Front Med (Lausanne) 6, 74 (2019).","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"95950_CR17","doi-asserted-by":"publisher","first-page":"dlad038","DOI":"10.1093\/jacamr\/dlad038","volume":"5","author":"A Olalekan","year":"2023","unstructured":"Olalekan, A. et al. High incidence of carbapenemase-producing Pseudomonas aeruginosa clinical isolates from Lagos, Nigeria. JAC Antimicrob Resist 5(2), dlad038 (2023).","journal-title":"JAC Antimicrob Resist"},{"key":"95950_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fpubh.2020.00003","volume":"8","author":"B Magalhaes","year":"2020","unstructured":"Magalhaes, B. et al. Combining standard molecular typing and whole genome sequencing to investigate Pseudomonas aeruginosa epidemiology in intensive care units. Front Public Health 8, 3 (2020).","journal-title":"Front Public Health"},{"issue":"6","key":"95950_CR19","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1128\/AAC.48.6.2043-2048.2004","volume":"48","author":"D Girlich","year":"2004","unstructured":"Girlich, D., Naas, T. & Nordmann, P. Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa. Antimicrob Agents Chemother 48(6), 2043\u20132048 (2004).","journal-title":"Antimicrob Agents Chemother"},{"key":"95950_CR20","doi-asserted-by":"publisher","first-page":"154699","DOI":"10.1016\/j.scitotenv.2022.154699","volume":"829","author":"RT Torres","year":"2022","unstructured":"Torres, R. T., Cunha, M. V., Ferreira, H., Fonseca, C. & Palmeira, J. D. A high-risk carbapenem-resistant Pseudomonas aeruginosa clone detected in red deer (Cervus elaphus) from Portugal. Sci Total Environ 829, 154699 (2022).","journal-title":"Sci Total Environ"},{"issue":"12","key":"95950_CR21","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1007\/s10096-021-04287-2","volume":"40","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. The prevalence and functional characteristics of CrpP-like in Pseudomonas aeruginosa isolates from China. Eur J Clin Microbiol Infect Dis 40(12), 2651\u20132656 (2021).","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"95950_CR22","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/antibiotics10121539","volume":"10","author":"D Pandey","year":"2021","unstructured":"Pandey, D., Singhal, N. & Kumar, M. Investigating the OXA variants of ESKAPE pathogens. Antibiotics (Basel) 10(12), 1539 (2021).","journal-title":"Antibiotics (Basel)"},{"issue":"12","key":"95950_CR23","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1099\/jmm.0.001106","volume":"68","author":"A Petrova","year":"2019","unstructured":"Petrova, A., Feodorova, Y., Miteva-Katrandzhieva, T., Petrov, M. & Murdjeva, M. First detected OXA-50 carbapenem-resistant clinical isolates Pseudomonas aeruginosa from Bulgaria and interplay between the expression of main efflux pumps, OprD and intrinsic AmpC. J Med Microbiol 68(12), 1723\u20131731 (2019).","journal-title":"J Med Microbiol"},{"issue":"2","key":"95950_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/microorganisms9020388","volume":"9","author":"M Hernandez-Garcia","year":"2021","unstructured":"Hernandez-Garcia, M. et al. Presence of chromosomal crpP-like genes is not always associated with ciprofloxacin resistance in Pseudomonas aeruginosa clinical isolates recovered in ICU patients from Portugal and Spain. Microorganisms 9(2), 388 (2021).","journal-title":"Microorganisms"},{"issue":"W1","key":"95950_CR25","doi-asserted-by":"publisher","first-page":"W256","DOI":"10.1093\/nar\/gkz239","volume":"47","author":"I Letunic","year":"2019","unstructured":"Letunic, I. & Bork, P. Interactive tree of life (iTOL) v4: Recent updates and new developments. Nucleic Acids Res 47(W1), W256\u2013W259 (2019).","journal-title":"Nucleic Acids Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95950-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95950-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95950-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T10:50:06Z","timestamp":1744714206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95950-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95950"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95950-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12932"}}